卑詩省和臺灣

臺灣的地理位置使其有可能成為更廣闊的亞洲市場新進入者的區域樞紐，更容易進入和分銷東亞和東南亞。臺灣是全球技術供應鏈的重要樞紐，具有高度創新性，在專利申請中排名第一。臺灣還擁有良好的基礎設施、受過高等教育的工作力，並且對國際貿易非常開放。

貿易與投資亮點

臺灣和加拿大正在進行討論，以促進供應鏈彈性、商業機會，並加強在科學、技術和創新、教育和綠色經濟方面的合作。
參與更多貿易協定的計劃將為台灣的出口開啟更多市場。
通過加拿大的印太戰略，加拿大將與澳大利亞、紐西蘭和臺灣等退出夥伴以及參與經濟體的原住民合作，通過實施《原住民經貿合作安排》（IPETCA），支援原住民的經濟賦權。

臺灣一覽

貨幣數位以美元為單位

外國投資者和卑詩省出口商的機會

農業食品和海鮮

Taiwan imports most of its food supply. The import of seafood products has grown substantially in recent years, creating significant opportunities for B.C.’s high-quality Agrifood and Seafood products in Taiwan. Vegetarian food and plant-based protein products are likely to find success in Taiwan due to the high rate of vegetarianism in the population.

清潔技術與清潔能源

B.C.’s advantages in cleantech research pairs naturally with Taiwan’s expertise in high-tech manufacturing, to help transform designs and concepts into tangible, marketable products. As Taiwan phases out its nuclear power program and decreases oil and coal consumption, the demand for LNG and renewable energy will grow significantly. B.C. is well-positioned to be a valuable partner to Taiwan, as it transitions its energy supply both through LNG exports and the clean energy technologies over the longer term. Hydrogen fuel cell technology, as a renewable source of energy, is also highly attractive as Taiwan attempts to meet 2050 emissions targets.

資訊通信技術

Taiwan is a major international player for semi-conductors and integrated circuits. Government policies prioritize innovation and developing the tech sector. There are many opportunities to be found in segments involving the Internet of Things (IOT), Artificial Intelligence (AI), ICT, agritech, online gaming, fintech, digital health, smart manufacturing, and smart transportation.

生命科學

Taiwan has been investing in its biotech sector since the 1980s. In 2021, the government amended the Development of Biotech and New Pharmaceutical Industry Act with the aim of generating opportunities in the biotechnology sector by attracting greater investment.

Taiwan’s pharmaceutical companies act mostly as Contract Development & Manufacturing Organizations (CDMO) and are historically strong in the generic drugs development and manufacturing.

Areas that present significant opportunities for B.C. firms include pharmaceutical products, medical devices and instruments, and health services, such as conducting clinical trials, licencing new intellectual property, and regulatory approval consultancy.